ClinicalTrials.gg
CompletedNCT06894277iTRAC-HEROUpdated Oct 1, 2026

An Interactive Education Program to Reduce High Risk Behavior in Adolescents Ph II (iTRAC HERO)

An interventional study of iTRAC-HERO in Risky Sexual Behavior, Emotion Regulation and Adolescent Behavior, sponsored by Klein Buendel, Inc.. Completed at 1 site in United States. Open to participants aged 12 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Klein Buendel, Inc. · Not applicable, Interventional, and Prevention

Updated Oct 1, 2026Now CompletedEnrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
12 Years to 14 Years
Sex
All
01

Study summary

Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will create and test iTRAC-HERO to teach emotion regulation skills in the context of sexual health education.

Read the detailed description

Adolescence is a critical developmental period during which behavioral patterns are formed that have powerful influences on current and future health. This is particularly true for sexual behavior, which is affected by the biological changes of puberty as well as normative developmental tasks around sexual exploration. Engaging in sexual behavior in early adolescence (before age 15) is associated with more partners, less condom use, and more frequent sex as teens get older, and these factors increase risk for negative health outcomes (e.g., sexually transmitted infections and unplanned pregnancy) throughout their lives. Many sexual health interventions teach prevention skills, such as assertiveness or condom use; the premise of the current application is that these skills are often unused by adolescents because of deficits in emotion regulation (ER), which is unaddressed in most sexual health education. Our research team has developed and tested a novel, engaging, efficacious, and developmentally tailored group intervention (Project TRAC) to teach ER skills to early adolescents within the context of sexual health. A study of Project TRAC showed that participants taught ER skills were less likely to start having sex over the 2.5 year follow up. While efficacious, the small group format of the Adolescence is a critical developmental period during which behavioral patterns are formed that have powerful influences on current and future health. This is particularly true for sexual behavior, which is affected by the biological changes of puberty as well as normative developmental tasks around sexual exploration. Engaging in sexual behavior in early adolescence (before age 15) is associated with more partners, less condom use, and more frequent sex as teens get older, and these factors increase risk for negative health outcomes (e.g., sexually transmitted infections and unplanned pregnancy) throughout their lives. Many sexual health interventions teach prevention skills, such as assertiveness or condom use; the premise of the current trial is that these skills are often unused by adolescents because of deficits in emotion regulation (ER), which is un-addressed in most sexual health education. The research team has developed and tested a novel, engaging, efficacious, and developmentally tailored group intervention (Project TRAC) to teach ER skills to early adolescents within the context of sexual health. A study of Project TRAC showed that participants taught ER skills were less likely to start having sex over the 2.5 year follow up. While efficacious, the small group format of the program presents barriers to sustainability and dissemination; significant advantages of web-based delivery exist. To explore whether the ER concepts of TRAC could be taught in a web-based format, the investigators completed a pilot study to translate TRAC's ER content to a web-based intervention (iTRAC), using Designing for Dissemination principles that enhance the likelihood of successful dissemination upon completion. iTRAC demonstrated feasibility and acceptability, and a randomized trial showed that iTRAC participants reported significantly better emotional competence compared to waitlist control participants. This study will complete the technology adaptation of the program to include its sexual health content and content linking ER to sexual health. This phase will create iTRAC-HERO as a web app. Once completed, acceptability testing will be completed with early adolescents to allow for modifications based on participant feedback. Once finalized, a small RCT will assess impact on adolescents' self-efficacy for preventing sexual risk as well as engagement in sexual behaviors.

02

Conditions studied

  • Risky Sexual Behavior
  • Emotion Regulation
  • Adolescent Behavior

Keywords

  • Risky Sexual Behavior
  • Emotion Regulation
  • Adolescent Behavior
03

In context

Emotional Regulation

545 studies on the registry are indexed under Emotional Regulation; 188 are open to participants now.

This study's enrollment of 120 is above the median of 79 across 498 interventional studies indexed under Emotional Regulation.

Browse Emotional Regulation studies →

Lead sponsor

Klein Buendel, Inc. is the lead sponsor of 35 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Attending 7th grade
  • Between 12 and 14 years old
  • Parent/guardian speaks English or Spanish
  • Attending participating school

Exclusion criteria

Exclusion Criteria:

  • Unable to read at a 4th grade level
  • Have a sibling who has participated in the study
  • Have a development disorder
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • No intervention
    Waitlist Control

    Control participants will be assessed on the same schedule as the treatment condition and offered the intervention after 6-month follow-up.

  • Experimental
    iTRAC-HERO

    iTRAC-HERO is an 8-module, web-based intervention for middle school boys and girls to complete. Its goal is primary prevention of adolescent sexual risk behaviors by targeting emotion regulation and sexual self-efficacy. (e.g., to refuse sexual advances).

    Behavioral: iTRAC-HERO

Interventions

  • BehavioraliTRAC-HERO

    iTRAC-HERO will consist of eight, approximately 45-minute, "gamified" digital modules of 4-6 activities (games, videos, etc.). No instruction is needed to use the program. Content will use gender- and sexuality-inclusive language and avoid heteronormative descriptions of risk. This content will include strategies for (and practice with) recognizing and managing emotions, particularly in relation to sexual health situations, to enhance the likelihood that the emotion regulation and sexual health education provided can be applied to experiences that are emotionally arousing and lead to risk.

06

What researchers measure

Primary outcomes

  1. Change in Sexual Self-Efficacy (SSE) from baseline to 6 months.

    The Sexual Self-Efficacy Scale (12 items) will measure self-efficacy for safer sexual activity as a main outcome which will indicate iTRAC-HERO's efficacy and ability to promote healthier sexual behaviors with the full sample (not just those who are sexually active).

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  2. Change in Self Efficacy for HIV Prevention from baseline to 6 month.

    The Self-Efficacy for HIV Prevention Scale (12 items) assesses a range of behaviors related to prevention of HIV, other STIs, or unintended pregnancy, including refusing sexual behaviors, discussing sexual histories with partners, buying condoms, taking free condoms, carrying condoms, and asking a partner to use a condom.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

Secondary outcomes

  1. Change in Sexual Risk Cognition from baseline to 6 months

    The Sexuality Questionnaire for Adolescents (34 items) is a multiple choice test to assess sexual health knowledge and has been shown to be sensitive to intervention impact.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  2. Change in attitudes towards abstinence from baseline to 6 months

    The Abstinence Attitudes questionnaire assesses agreement with values related to abstinence (α= .86).

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  3. Change in frequency of sexual and substance use behaviors from baseline to 6 months

    The Adolescent Risk Behavior Assessment (ARBA) will assess sexual behavior, including behaviors relevant to this developmental period.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  4. Change in adolescent substance use behaviors from baseline to 6 months

    Youth Risk Behavior Surveillance System items will be used to assess tobacco/vape use, violence (e.g., fighting), and substance use behaviors.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

Other outcomes

  1. Change in Emotion Regulation Skills from baseline to 6 months

    The Difficulties in Emotion Regulation Scale (36 items) uses six subscales (e.g., lack of emotional awareness, limited access to ER strategies; all α \> .80) to assess perceptions of skill in ER based on Linehan's theoretical work.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  2. Change in frequency of dificulties with emotion regulation from baseline to 6 months

    The Affect Dysregulation Scale (6 items) assesses the frequency of difficulties with ER (α= .72), and is shown to be related to adolescent risk behaviors.

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  3. Change in usage of emotion regulation behaviors taught in iTRAC-HERO from baseline to 6 months

    The Emotion Regulation Behaviors Scale- Revised measures use of the specific emotion regulation strategies taught in iTRAC (α= .73).

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  4. Change in perceptions of one's ability to manage negative emotions from baseline to 6 months

    The Emotional Self-Efficacy Subscale of the Self-Efficacy Questionnaire for Children assesses perception of one's ability to cope with negative emotions (α= .83).

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

  5. Change in beliefs about controllability of emotions from baseline to 6 months

    The Implicit Theories of Emotions for Children Self subscale (6 items) is based on Dweck and colleagues' work on implicit theories of intelligence and Tamir's adult measure of emotion malleability. It assesses adolescents' beliefs about the controllability of their emotions (α=.86).

    Time frame: Baseline, 1 month post-intervention, 6 month follow up

07

Study locations

1 site
  • Klein Buendel, Inc.
    Golden, Colorado 80401, United States
08

References and documents

Individual participant data

Plan to share: Yes — The investigators will prepare an archival-quality data package for upload to the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH). Specifically, the investigators will provide documentation on the full data-audit trail from the exact prompts seen by participants, to the syntax used to score and aggregate items, to the finalized data ready for use by qualified investigators. The archival-quality data package will also include a codebook in line with the Data Documentation Initiative (DDI) and contains information about variables, metadata, and file structure. The metadata will include description of the trial, including design, implementation, and description of the interventions. The intent is to provide everything that future investigators require to understand the trial, analyze the data, correctly interpret the findings, and be able to publish new analyses that meet current publication standards for clinical trials and/or meta-analyses.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: After analyses are completed for the aims of the study.

Access criteria: The data package will be available for future investigators. For datasets that include potentially sensitive information, investigators not part of the original study will submit requests to be reviewed by the PIs. Qualified investigators who agree to terms of use and confidentiality agreements will be provided with deidentified data.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Recruiting→Completed
    + 4 other changes: verification date, date precision, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06894277
Responsible party
Sponsor
First posted
Mar 25, 2025
Start date
Apr 1, 2025
Primary completion
Aug 8, 2026
Completion
Aug 31, 2026
Last update
Oct 1, 2026

Study contacts

Christopher Houck, PhD
principal investigator · Rhode Island Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion